Clobetasone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clobetasone
Clobetasone.png
Systematic (IUPAC) name
(1R,2S,10S,11S,13S,14R,15S)-14-(2-chloroacetyl)-1-fluoro-14-hydroxy-2,13,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-diene-5,17-dione
Clinical data
Trade names Eumovate
AHFS/Drugs.com Micromedex Detailed Consumer Information
Legal status
?
Routes topical
Identifiers
CAS number 54063-32-0 YesY
ATC code D07AB01 S01BA09
PubChem CID 71387
ChemSpider 64482 YesY
UNII LT69WY1J6D YesY
KEGG D07717 YesY
Synonyms (8S,9R,10S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthrene-3,11-dione
Chemical data
Formula C22H26ClFO4 
Molecular mass 408.891 g/mol
 YesY (what is this?)  (verify)

Clobetasone (INN[1]) is a corticosteroid used in dermatology, for treating such skin inflammation as seen in eczema, psoriasis and other forms of dermatitis, and ophthalmology. Topical clobetasone butyrate has shown minimal suppression of the Hypothalamic-pituitary-adrenal axis.[2]

It is available as clobetasone butyrate under the brand names Eumosone or Eumovate[3] both manufactured by GlaxoSmithKline.

Trimovate also contains Oxytetracycline, an antibiotic, and nystatin, an antifungal.[4][5][6]

Uses[edit]

In dermatology, topical clobestasone butyrate helps to reduce the itchiness and erythema associated with eczema and dermatitis.[7]

In ophthalmology, clobetasone butyrate 0.1% eye drops have been shown to be safe and effective in the treatment of dry eyes in Sjögren's Syndrome. Sjögren's Syndrome is an autoimmune disorder that affects the moisture producing glands of the body causing many symptoms including dry eyes.[8] When compared to other corticosteroid eye drops; clobetasone butyrate showed only minimal rises in intraocular pressure. Increased pressure within the eye can lead to glaucoma.[9][10][11]

Adverse effects[edit]

Side effects associated with clobetasone cream and ointment include: burning, irritation, itching, thinning of the skin, and changes in skin color.[12][13]

References[edit]

  1. ^ United Nations Statistics Division - Classifications Registry - Alphabetical index for HS 2002 Entries starting with 'C' (page 310 of 422)
  2. ^ Munro, D. D.; Wilson, L (1975). "Clobetasone butyrate, a new topical corticosteroid: Clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy". British medical journal 3 (5984): 626–8. PMC 1674413. PMID 1164639.  edit
  3. ^ Eumovate cream/ointment, NetDoctor.co.uk
  4. ^ 30g Trimovate Cream Box, GSK
  5. ^ Medicines.org.uk - Trimovate info
  6. ^ Trimovate cream, NetDoctor.co.uk
  7. ^ Euvomate Medication Guide, GlaxoSmithKline
  8. ^ Aragona, P; Spinella, R; Rania, L; Postorino, E; Sommario, M. S.; Roszkowska, A. M.; Puzzolo, D (2013). "Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjögren syndrome". European Journal of Ophthalmology 23 (3): 368–76. doi:10.5301/ejo.5000229. PMID 23225089.  edit
  9. ^ Ramsell, T. G.; Bartholomew, R. S.; Walker, S. R. (1980). "Clinical evaluation of clobetasone butyrate: A comparative study of its effects in postoperative inflammation and on intraocular pressure". The British journal of ophthalmology 64 (1): 43–5. PMC 1039346. PMID 6986899.  edit
  10. ^ Wilhelmus, K. R.; Hunter, P. A.; Rice, N. S. (1981). "Equivalence of topical clobetasone and dexamethasone in experimental corneal allograft rejection". The British journal of ophthalmology 65 (10): 699–701. PMC 1039641. PMID 7032579.  edit
  11. ^ Eilon, L. A.; Walker, S. R. (1981). "Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure". The British journal of ophthalmology 65 (9): 644–7. PMC 1039614. PMID 7028089.  edit
  12. ^ Clobetason Butyrate, WebMD
  13. ^ Euvomate Medication Guide, GlaxoSmithKline